Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer (LIGHTHOUSE)
Condition: Prostate Cancer Intervention: Drug: rhPSMA-7.3 (18F) Injection Sponsors: Blue Earth Diagnostics; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials